Sandoz Group AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SDZXF | MRK.F | 000230.KS | 1795.TW | 3KY.F | 000623.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 42.59B | 65.87B | 65.20B | 44.76B | 23.84B | 20.71B |
| P/E (TTM) | 67.0 | 27.8 | — | 11.8 | 30.2 | 6.8 |
| Forward P/E | — | 16.7 | — | 7.1 | — | 7.9 |
| Price/book | 4.8 | 2.2 | — | 1.9 | 4.7 | 0.6 |
| Dividend yield | 1.04% | 1.49% | 1.79% | 1.61% | 1.54% | 2.88% |
| 1-year change | +48.47% | +37.23% | −52.38% | −42.88% | −6.72% | −16.84% |
| Today | 0.00% | +0.50% | +0.89% | +5.66% | +3.83% | −0.35% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All SDZXF news ›Sandoz Group AG (SDZNY) Q3 2026 Sales/ Trading Statement Call - Slideshow
2026-11-02. The following slide deck was published by Sandoz Group AG in conjunction with this event. The following slide deck was published by Sandoz Group AG in conjunction with this event.
Sandoz v Novo Nordisk and Effective Protection for Patent Challengers
The Court decided a preliminary objection. It neither determined validity nor granted a declaration or an interim measure. It also found the evidence insufficient to establish misconduct by Novo Nordisk at this stage. Within those
Sandoz wins accolade In-house Team of the Year for Patent Germany
It's official: At this year's JUVE Awards Germany, Sandoz has won in the category In-house Team of the Year for Patent. The pharmaceutical company has established a successful patent strategy only three years after its spin off from…
Sandoz falls as headwinds in Germany prompt cautious outlook
Sandoz (SDZNY) stock dropped as the company cuts its outlook with its Q3 2026 sales, which also fell short of forecasts amid market headwinds in Germany. Read more here. Shares of Sandoz (SDZNY) (SDZXF) closed lower in Europe on Tuesday…
Generic drugmaker Sandoz lowers sales outlook, lifts profit forecast
ZURICH, Oct 28 (Reuters) – Swiss generic drugmaker Sandoz on Wednesday lowered its full-year sales growth guidance and lifted its core earnings margin forecasts after short-term biosimilar-supply constraints weighed on third-quarter…
Sandoz Group Ltd News — XETR:D8Y
Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business…
Antitrust Law Daily Wrap Up, ANTITRUST—D. Conn.: States win preliminary approval of $400M Sandoz generic drug price-fixing settlement, (Oct 19, 2026)
By Kenneth H. Ryesky, M.B.A., J.D. Sandoz's total settlement payouts in the generic pharmaceutical antitrust litigation cases brought by U.S. state attorneys general could top $1 billion. Additional cases regarding Sherman Act claims…
Suits Linking Tylenol To Autism, $400M Sandoz Deal And More
By Gianna Ferrarin · October 20, 2026, 7:49 PM EDT Connecticut et al v. Aurobindo Pharma USA, Inc. et al In Re: National Prescription Opiate Litigation Connecticut et al v. Teva Pharmaceuticals USA, Inc. Connecticut et al v. Sandoz, Inc.…
States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal
Law360 States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal By Brian Steele · October 16, 2026, 5:37 PM EDT /healthcare-authority/tracked_cases?case_id=5852d2620b3a4c66f0000001&case_title=Connecticut+et+al+v.+Aurobindo+Pharma+USA%2
Who's Eligible to Claim Money from the Generic Drug Price-Fixing Settlement with Sandoz?
Sandoz will pay $400 million to settle generic drug price-fixing allegations with 48 states. Americans who bought certain generic medications may be eligible for compensation. Here's how to file a claim and what the settlement may mean for…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- seekingalpha.com3
- law360.com2
- finance.biggo.com1
- freedom959.net1
- juve-patent.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.